VRTX
NASDAQStockVertex Pharmaceuticals Incorporated
$479.41-13.10 (-2.66%)
52-Week Range
$366.54
$513.76
Key Stats
Market Cap
121.8B
P/E Ratio
N/A
Dividend Yield
N/A
Beta
0.32
Volume
940.1K
Avg Volume
1.4M
Performance
1M
+6.24%
3M
+8.92%
6M
+25.22%
YTD
+8.90%
1Y
-0.61%
3Y
+67.78%
5Y
+124.17%
Price Chart
ETF Exposure
VRTX is held by 370 ETFs
| ETF | Fund Name | Weight |
|---|---|---|
| USMV | iShares MSCI USA Min Vol Factor ETF | 1.56% |
| IWLG | NYLI Winslow Large Cap Growth ETF | 1.56% |
| ASLV | Allspring Special Large Value ETF | 1.50% |
| CGDV | Capital Group Dividend Value ETF | 1.48% |
| HTEC | ROBO Global Healthcare Technology and Innovation ETF | 1.48% |
| WDNA | WisdomTree BioRevolution Fund | 1.47% |
| CGGO | Capital Group Global Growth Equity ETF | 1.40% |
| XBI | State Street SPDR S&P Biotech ETF | 1.37% |
| CGBL | Capital Group Core Balanced ETF | 1.34% |
| SYG | SPDR MFS Systematic Growth Equity ETF | 1.31% |
| AGRW | Allspring LT Large Growth ETF | 1.30% |
| JAVA | JPMorgan Active Value ETF | 1.21% |
| LGRO | Level Four Large Cap Growth Active ETF | 1.19% |
| PJFG | PGIM Jennison Focused Growth ETF | 1.16% |
| FFLS | The Future Fund Long/Short ETF | 1.16% |
| QQQE | Direxion NASDAQ-100 Equal Weighted Index ETF | 1.10% |
| NULC | Nuveen ESG Large-Cap | 1.08% |
| JEPI | JPMorgan Equity Premium Income ETF | 1.06% |
| CLRG | IQ Chaikin U.S. Large Cap ETF | 1.04% |
| FXH | First Trust Health Care AlphaDEX Fund | 1.01% |
| HFGO | Hartford Large Cap Growth ETF | 0.98% |
| MEDI | Harbor Health Care ETF (MEDI) | 0.98% |
| QQQG | Pacer Nasdaq-100 Top 50 Cash Cows Growth Leaders ETF | 0.96% |
| CTRU | ARK Transparency ETF | 0.95% |
| SPMV | Invesco S&P 500 Minimum Variance ETF | 0.90% |
| STNC | Hennessy Sustainable ETF | 0.88% |
| JOET | Virtus Terranova U.S. Quality Momentum ETF | 0.87% |
| FCTR | First Trust Lunt U.S. Factor Rotation ETF | 0.83% |
| QUS | State Street SPDR MSCI USA StrategicFactors ETF | 0.82% |
| ENDW | Cambria Endowment Style ETF | 0.81% |
| NUSI | Nationwide Nasdaq-100 Risk-Managed Income ETF | 0.81% |
| LRGC | Alliance Bernstein - AB US Large Cap Strategic Equities ETF | 0.76% |
| GTPE | Goldman Sachs MSCI World Private Equity Return Tracker ETF | 0.76% |
| AVIE | Avantis Inflation Focused Equity ETF | 0.75% |
| MODL | VictoryShares WestEnd U.S. Sector ETF | 0.74% |
| JEPQ | JPMorgan Nasdaq Equity Premium Income ETF | 0.73% |
| MMLG | First Trust Multi-Manager Large Growth ETF | 0.73% |
| ASPY | ASYMshares ASYMmetric S&P 500 ETF | 0.71% |
| XT | iShares Future Exponential Technologies ETF | 0.70% |
| QB | ProShares - Nasdaq-100 Dynamic Buffer ETF | 0.69% |
| QQQ | Invesco QQQ Trust, Series 1 | 0.68% |
| QQQM | Invesco NASDAQ 100 ETF | 0.68% |
| GPIQ | Goldman Sachs Nasdaq-100 Premium Income ETF | 0.68% |
| QHDG | Innovator Hedged Nasdaq-100 ETF | 0.67% |
| QQQI | NEOS Nasdaq-100 High Income ETF | 0.67% |
| COWG | Pacer US Large Cap Cash Cows Growth Leaders ETF | 0.66% |
| QTR | Global X - Nasdaq 100 Tail Risk ETF | 0.66% |
| CRTC | Xtrackers US National Critical Technologies ETF | 0.66% |
| QQQH | NEOS Nasdaq-100 Hedged Equity Income ETF | 0.66% |
| QCLR | Global X - Nasdaq 100 Collar 95-110 ETF | 0.65% |
About VRTX ETF Exposure
Vertex Pharmaceuticals Incorporated (VRTX) is held by 370 exchange-traded funds, making it one of the stocks with significant ETF exposure. With a market capitalization of 121.8B, VRTX is a widely held institutional stock. The stock currently trades at $479.41. Investors can gain exposure to VRTX through a variety of ETFs with different expense ratios, investment strategies, and portfolio weightings. The table above shows all ETFs that currently hold VRTX, sorted by portfolio weight.